Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (829)
All Articles published online
|
Publishing Process of This Article
|
Oct 24, 2025 (publication date) through Feb 23, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Tom L, Mani S, Rawat A, Nan M, Mundada SM, Al Khatib B, Gopinath A, Taj O, Salahuddin N, Shaju F, Parsa S, Abdurrahman M, Das A, Khawar MMH, Sher A. Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes. World J Clin Oncol 2025; 16(10): 112392 [PMID: 41178922 DOI: 10.5306/wjco.v16.i10.112392] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Tom L, Mani S, Rawat A, Nan M, Mundada SM, Al Khatib B, Gopinath A, Taj O, Salahuddin N, Shaju F, Parsa S, Abdurrahman M, Das A, Khawar MMH, Sher A. Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes. World J Clin Oncol 2025; 16(10): 112392 [PMID: 41178922 DOI: 10.5306/wjco.v16.i10.112392] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i10/112392.htm |
| Number | Citing Articles |
| 1 |
Faisal Nabi Depar, Ahmed Jamal Chaudhary, Jawad Hameed, Faisal Sarwar Abbasi, Bibi Uzma, Amjad Ali, Naheed Akhtar, Rizwan Khan, Afsheen Siddiqi, Sohail Riaz. Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. World Journal of Clinical Oncology 2026; 17(2): 116251 doi: 10.5306/wjco.v17.i2.116251
Abstract(15) |
Core Tip(24) |
Full Article(HTML)(66)
|
Full Article with Cover (PDF)-953K(9)
|
Audio-145K(3)
|
Peer-Review Report-301K(9)
|
Answering Reviewers-88K(10)
|
Supplementary Material-176K(11)
|
Full Article (PDF)-727K(14)
|
Full Article (XML)-112K(8)
|
Times Cited (0)
|
Total Visits (603)
|
Open
|